February 28, 2005

Lessons from Cox-2 drug marketing

The San Francisco Chronicle reports on how "the painkillers Vioxx, Celebrex and Bextra may go down in history as a classic example of the danger posed by aggressive industry promotion of prescription drugs to both patients and doctors."

But some say that if the FDA tries to block consumer advertising for the drugs permanently, it could be headed for a showdown based on a First Amendment challenge.

A former FDA deputy commissioner said, "You don't have a First Amendment right to lie, to say false and misleading things."

Posted by schwitz at February 28, 2005 10:53 AM
Comments
The views and opinions expressed in this page are strictly those of the page author. The contents of this page have not been reviewed or approved by the University of Minnesota.